400 related articles for article (PubMed ID: 19328972)
21. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
Marcén R; Chahin J; Alarcón A; Bravo J
Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
[TBL] [Abstract][Full Text] [Related]
22. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
[TBL] [Abstract][Full Text] [Related]
23. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
24. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin II type-1 receptor blockers on stable allograft kidneys: prospective randomized study.
Nouri-Majalan N; Ghafari A; Moghaddasi S
Transplant Proc; 2009 Sep; 41(7):2832-4. PubMed ID: 19765449
[TBL] [Abstract][Full Text] [Related]
26. [Primary hyperlipidemia in children and adolescents: effects of dietary and pharmacological intervention].
Muñoz Calvo MT; Argente Oliver J; Cocho Gómez P; Barrios Sabador V; Bonet Serra B; Hernández Rodríguez M
An Esp Pediatr; 1996 Oct; 45(4):386-92. PubMed ID: 9005726
[TBL] [Abstract][Full Text] [Related]
27. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
Holcombe SM; Brubaker PH
J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
[TBL] [Abstract][Full Text] [Related]
28. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
[TBL] [Abstract][Full Text] [Related]
29. The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
Marshall DA; Vernalis MN; Remaley AT; Walizer EM; Scally JP; Taylor AJ
Am Heart J; 2006 Feb; 151(2):484-91. PubMed ID: 16442919
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
[TBL] [Abstract][Full Text] [Related]
31. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
[TBL] [Abstract][Full Text] [Related]
33. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL
Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
Cromwell WC; Otvos JD
Am J Cardiol; 2006 Dec; 98(12):1599-602. PubMed ID: 17145217
[TBL] [Abstract][Full Text] [Related]
35. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
[TBL] [Abstract][Full Text] [Related]
36. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein cholesterol goal attainment among high-risk patients: Does a combined intervention targeting patients and providers work?
Afonso NM; Nassif G; Aranha AN; Delor B; Cardozo LJ
Am J Manag Care; 2006 Oct; 12(10):589-94. PubMed ID: 17026413
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, body fat percentage, and lipid abnormalities as risk factors for cardiovascular diseases in renal transplant recipients: a 1-year analysis.
Souza GC; Costa CA; Gonçalves LF; Manfro RC
Transplant Proc; 2008 Apr; 40(3):761-3. PubMed ID: 18455009
[TBL] [Abstract][Full Text] [Related]
39. Hyperlipidemia in children after heart transplantation.
Singh TP; Naftel DC; Webber S; Dupuis J; Chin C; Spicer R; Schowengerdt KO; Ring WS; Morrow WR;
J Heart Lung Transplant; 2006 Oct; 25(10):1199-205. PubMed ID: 17045932
[TBL] [Abstract][Full Text] [Related]
40. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
Lake KD; Reutzel TJ; Pritzker MR; Jorgensen CR; Emery RW
J Heart Lung Transplant; 1993; 12(4):580-90. PubMed ID: 8369320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
